IMOT Intensive Therapy
94% of children achieve motor improvements in camp format. 60-120 hour intensive delivery. Emerging evidence for CP and ABI populations.
Each lens uses its own dimensions and default weights. Scores answer different questions across paths — they aren’t apples-to-apples. How scoring works →
94% improvement rate is promising; comparison to dose-matched conventional therapy is the key test and evidence is emerging.
Very specialized for children with neurological conditions in intensive therapy settings; limited US availability.
Billed as intensive PT/OT; variable US payer coverage; international origins limit domestic payer recognition.
Specialized intensive program training; limited sites; significant time commitment; international origins.
Limited US employer demand; primarily academic pediatric centers.
Children and families report high satisfaction; peer social environment adds value.
Pediatric intensive model is overwhelmingly cash-pay; parents of children with CP/neuro conditions readily pay.
Burst-care model commands premium block pricing (often $3-8K per intensive).
Distinctive service model that stands out from traditional outpatient peds.
Other trained clinicians can deliver intensives; model scales with staff and facility.
Strong within pediatric neuro parent communities; modest broader awareness.
Moderate training cost; profitable model once operational.
Not a recognized credential for academic promotion.
Limited peer-reviewed literature specific to IMOT branding.
Relevant to peds neuro instruction as a service-delivery model.
Intensive model has some support (HABIT, CIMT literature) but IMOT-specific evidence is thin.
Rarely if ever named in faculty postings.
Short course relative to academic return, but academic return is low.